567 related articles for article (PubMed ID: 38372868)
1. Delineating the role of nuclear receptors in colorectal cancer, a focused review.
Manickasamy MK; Jayaprakash S; Girisa S; Kumar A; Lam HY; Okina E; Eng H; Alqahtani MS; Abbas M; Sethi G; Kumar AP; Kunnumakkara AB
Discov Oncol; 2024 Feb; 15(1):41. PubMed ID: 38372868
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptors in oral cancer-Emerging players in tumorigenesis.
Gangwar SK; Kumar A; Jose S; Alqahtani MS; Abbas M; Sethi G; Kunnumakkara AB
Cancer Lett; 2022 Jun; 536():215666. PubMed ID: 35364221
[TBL] [Abstract][Full Text] [Related]
3. Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.
Jayaprakash S; Hegde M; Girisa S; Alqahtani MS; Abbas M; Lee EHC; Yap KC; Sethi G; Kumar AP; Kunnumakkara AB
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142861
[TBL] [Abstract][Full Text] [Related]
4. Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.
Gangwar SK; Kumar A; Yap KC; Jose S; Parama D; Sethi G; Kumar AP; Kunnumakkara AB
Pharmaceuticals (Basel); 2022 May; 15(5):. PubMed ID: 35631448
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration.
Oh CK; Cho YS
Intest Res; 2024 Apr; 22(2):131-151. PubMed ID: 38295766
[TBL] [Abstract][Full Text] [Related]
6. Emerging trends in colorectal cancer: Dysregulated signaling pathways (Review).
Ahmad R; Singh JK; Wunnava A; Al-Obeed O; Abdulla M; Srivastava SK
Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33655327
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways.
Postwala H; Shah Y; Parekh PS; Chorawala MR
Med Oncol; 2023 Oct; 40(11):334. PubMed ID: 37855910
[TBL] [Abstract][Full Text] [Related]
8. Roles of Nuclear Receptors in Esophageal Cancer.
Deng L; Liu J; Chen WD; Wang YD
Curr Pharm Biotechnol; 2023; 24(12):1489-1503. PubMed ID: 36740804
[TBL] [Abstract][Full Text] [Related]
9. The significance of microRNA deregulation in colorectal cancer development and the clinical uses as a diagnostic and prognostic biomarker and therapeutic agent.
Ahadi A
Noncoding RNA Res; 2020 Sep; 5(3):125-134. PubMed ID: 32954092
[TBL] [Abstract][Full Text] [Related]
10. Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved.
Afrin S; Giampieri F; Gasparrini M; Forbes-Hernández TY; Cianciosi D; Reboredo-Rodriguez P; Zhang J; Manna PP; Daglia M; Atanasov AG; Battino M
Biotechnol Adv; 2020; 38():107322. PubMed ID: 30476540
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
[TBL] [Abstract][Full Text] [Related]
12. Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc.
Wang YN; Ruan DY; Wang ZX; Yu K; Rong DL; Liu ZX; Wang F; Hu JJ; Jin Y; Wu QN; Pu HY; Wang M; Xu RH; Zeng ZL
Oncogene; 2022 Dec; 41(49):5266-5278. PubMed ID: 36316442
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.
Yang Y; Yan X; Li X; Ma Y; Goel A
Cancer Lett; 2021 Apr; 504():67-80. PubMed ID: 33577977
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism.
Wai Hon K; Zainal Abidin SA; Othman I; Naidu R
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32878019
[TBL] [Abstract][Full Text] [Related]
15. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
[TBL] [Abstract][Full Text] [Related]
16. Nuclear receptor: Structure and function.
Sar P
Prog Mol Biol Transl Sci; 2023; 196():209-227. PubMed ID: 36813359
[TBL] [Abstract][Full Text] [Related]
17. SPRY4-IT1 promotes survival of colorectal cancer cells through regulating PDK1-mediated glycolysis.
Liu S; Huang F; Ye Q; Li Y; Chen J; Huang H
Anim Cells Syst (Seoul); 2020 Jun; 24(4):220-227. PubMed ID: 33029299
[TBL] [Abstract][Full Text] [Related]
18. The critical role of calcineurin/NFAT (C/N) pathways and effective antitumor prospect for colorectal cancers.
Gang W; Yu-Zhu W; Yang Y; Feng S; Xing-Li F; Heng Z
J Cell Biochem; 2019 Dec; 120(12):19254-19273. PubMed ID: 31489709
[TBL] [Abstract][Full Text] [Related]
19. Absent in melanoma 2 attenuates proliferation and migration and promotes apoptosis of human colorectal cancer cells by activating P38MAPK signaling pathway.
Zhang Z; Li X; Zhang Y; Zhu H; Qiao Z; Lu Y; Mi X; Cao H; Shen G; He S
Oncol Res; 2023; 32(2):353-360. PubMed ID: 38186575
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
